| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445919 | European Journal of Cancer | 2012 | 11 Pages |
Abstract
This is the first controlled trial evaluating an entirely novel cancer treatment modality delivering electric fields rather than chemotherapy. No improvement in overall survival was demonstrated, however efficacy and activity with this chemotherapy-free treatment device appears comparable to chemotherapy regimens that are commonly used for recurrent glioblastoma. Toxicity and quality of life clearly favoured TTF.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Roger Stupp, Eric T. Wong, Andrew A. Kanner, David Steinberg, Herbert Engelhard, Volkmar Heidecke, Eilon D. Kirson, Sophie Taillibert, Frank Liebermann, Vladimir Dbalý, Zvi Ram, J. Lee Villano, Nikolai Rainov, Uri Weinberg, David Schiff, Lara Kunschner,